Falls in parkinson disease: Analysis of a large cross-sectional cohort

Journal of Parkinson's Disease

Volumn 3, Issue 4, 2013, Pages 515-522

  Parashos, Sotirios A ^a   Wielinski, Catherine L ^a   Giladi, Nir ^b   Gurevich, Tanya ^b  

^a Struthers Parkinson's Center   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Antidepressants; Cognitive dysfunction; Falls; Parkinson disease

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

AGE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAIN DEPTH STIMULATION; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DATA BASE; DIABETES MELLITUS; DISEASE DURATION; DRUG USE; FALL RISK; FALLING; FEMALE; FOLLOW UP; GENDER; HOEHN AND YAHR SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEUROLOGIC DISEASE; ONSET AGE; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PARKINSON DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEMANTICS; STANDING; TREMOR; VERBAL MEMORY; WORD RECOGNITION;

ANTIDEPRESSANTS; COGNITIVE DYSFUNCTION; FALLS; PARKINSON DISEASE;

ACCIDENTAL FALLS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84898748547     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130249     Document Type: Article

References (42)

1. Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M,&Parashos SA (2005) Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord, 20, 410-415.
2. Koller WC, Glatt S, Vetere-Overfield B, & Hassanein R (1989) Falls and Parkinson's disease. Clin Neuropharmacol, 12, 98-105.
3. Schrag A, Jahanshahi M, & Quinn NP (2001) What contributes to depression in Parkinson's disease? Psychol Med, 31, 65-73.
4. Martignoni E, Godi L, Citterio A, Zangaglia R, Riboldazzi G, Calandrella D, Pacchetti C, Nappi G, & Parkinson's Disease Comorbidity Study, Group (2004) Comorbid disorders and hospitalisation in Parkinson's disease: A prospective study. Neurol Sci, 25, 66-71.
5. Melton LJ 3rd, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, Rocca WA (2006) Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia. Mov Disord 21, 1361-1367.
6. Allyson Jones C,Wayne Martin WR,Wieler M, King-Jesso P, & Voaklander DC (2012) Incidence and mortality of Parkinson's disease in older Canadians. Parkinsonism Relat Disord, 18, 327-331.
7. Kaltenboeck A, Johnson SJ, Davis MR, Birnbaum HG, Carroll CA, Tarrants ML,&SiderowfAD(2012) Direct costs and survival of Medicare beneficiaries with early and advanced Parkinson's disease. Parkinsonism Relat Disord, 18, 321-326.
8. Michalowska M, Fiszer U, Krygowska-Wajs A, & Owczarek K (2005) Falls in Parkinson's disease. Causes and impact on patients' quality of life. Funct Neurol, 20, 163-168.
9. Rahman S, Griffin HJ, Quinn NP, & Jahanshahi M (2008) Quality of life in Parkinson's disease: The relative importance of the symptoms. Mov Disord, 23, 1428-1434.
10. Brozova H, Stochl J, Roth J, & Ruzicka E (2009) Fear of falling has greater influence than other aspects of gait disorders on quality of life in patients with Parkinson's disease. Neuro Endocrinol Lett 30, 453-457.
11. Schrag A, Hovris A, Morley D, Quinn N, & Jahanshahi M (2006) Caregiver-burden in Parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord, 12, 35-41.
12. Temlett JA, & Thompson PD (2006) Reasons for admission to hospital for Parkinson's disease. Intern Med J, 36, 524-526.
13. Vossius C, Nilsen OB,&Larsen JP (2010) Parkinson's disease and hospital admissions: Frequencies, diagnoses and costs. Acta Neurol Scand, 121, 38-43.
14. Roudsari BS, Ebel BE, Corso PS, Molinari NA, & Koepsell TD (2005) The acute medical care costs of fall-related injuries among the U.S. older adults. Injury, 36, 1316-1322.
15. Chung KA, Lobb BM, Nutt JG,&Horak FB (2010) Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology, 75, 1263-1269.
16. Allen NE, Sherrington C, Paul SS, & Canning CG (2011) Balance and falls in Parkinson's disease: A meta-analysis of the effect of exercise and motor training. Mov Disord, 26, 1605-1615.
17. Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, Shah L, Sackley C, Deane KH, Wheatley K, & Ives N (2012) Physiotherapy intervention in Parkinson's disease: Systematic review and meta-analysis. BMJ, 345, e5004.
18. Wood BH, Bilclough JA, Bowron A, & Walker RW (2002) Incidence and prediction of falls in Parkinson's disease: A prospective multidisciplinary study. J Neurol Neurosurg Psychiatry, 72, 721-725.
19. Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, & Giladi N (2005) Falls in outpatients with Parkinson's disease: Frequency, impact and identifying factors. J Neurol, 252, 1310-1315.
20. Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, Gray P, Kerr G, & Bloem BR (2007) A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord, 22(13), 1892-1900.
21. Okun MS, Siderowf A, Nutt JG, O'Conner GT, Bloem BR, Olmstead EM, Guttman M, Simuni T, Cheng E, Cohen EV, Parashos S, Marsh L, Malaty IA, Giladi N, Schmidt P, & Oberdorf J (2010) Piloting the NPF data-driven quality improvement initiative. Parkinsonism Relat Disord, 16, 517-521.
22. Hosmer DW, Lemeshow S, & Sturdivant RX (2013) Applied Logistic Regression 3rd Ed. John Wiley & Sons, Inc, Hoboken, New Jersey.
23. Todd C, Skelton D, & Health Evidence Network (2004) What are the Main Risk Factors for Falls Among Older People and What are the Most Effective Interventions to Prevent These Falls? World Health Organization, Geneva.
24. Post B, Merkus MP, de Haan RJ, & Speelman JD; Study CARPA Group (2007) Prognostic factors for the progression of Parkinson's disease: A systematic review. Mov Disord, 22, 1839-1851.
25. Selikhova M,Williams DR, Kempster PA, Holton JL, Revesz T, & Lees AJ (2009) A clinicopathological study of subtypes in Parkinson's disease. Brain, 132, 2947-2957.
26. Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, & Litvan I (1999) Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord, 14, 947-950.
27. Himes CL, & Reynolds SL (2012) Effect of obesity on falls, injury, and disability. J Am Geriatr Soc, 60, 124-129.
28. Dibble LE, & Lange M (2006) Predicting falls in individuals with Parkinson disease: A reconsideration of clinical balance measures. J Neurol Phys Ther, 30, 60-67.
29. Huang SL, Hsieh CL, Wu RM, Tai CH, Lin CH, & Lu WS (2011) Minimal detectable change of the timed 'up&go' test and the dynamic gait index in people with Parkinson disease. Phys Ther, 91, 114-121.
30. Flowers KA, Robertson C, & Sheridan MR (1995) Some characteristics of word fluency in Parkinson's disease. J Neurolinguist, 9, 33-46.
31. Henry JD, & Crawford JR (2004) Verbal fluency deficits in Parkinson's disease:Ameta-analysis. J Int Neuropsychol Soc, 10, 608-622.
32. Hausdorff JM, Doniger GM, Springer S, Yogev G, Simon ES, &Giladi N (2006) A common cognitive profile in elderly fallers and in patients with Parkinson's disease: The prominence of impaired executive function and attention. Exp Aging Res, 32, 411-429.
33. Allcock LM, Rowan EN, Steen IN,Wesnes K, Kenny RA, & Burn DJ (2009) Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord, 15, 110-115.
34. Yarnall A, Rochester L, & Burn DJ (2011) The interplay of cholinergic function, attention, and falls in Parkinson's disease. Mov Disord, 26, 2496-2503.
35. Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, & Tamblyn R (2012) Medication-related falls in the elderly: Causative factors and preventive strategies. Drugs Aging, 29, 359-376.
36. Masud T, Frost M, Ryg J, Matzen L, Ibsen M, Abrahamsen B, BrixenK(2013) Central nervous system medications and falls risk in men aged 60-75 years: The Study on Male Osteoporosis and Aging (SOMA). Age Ageing 42, 121-124.
37. Nutt JG, Siderowf AD, Guttman M, Nelson EC, Schmidt P, Zamudio J,Wu SS,&Okun MS; QII Investigators (2012) Correlates of health related quality of life (HRQL) in Parkinson's disease. Mov Disord 27(suppl 1), S175.
38. Burn DJ, Landau S, Hindle JV, Samuel M, Wilson KC, Hurt CS, & Brown RG; Study PROMS-PD Group (2012) Parkinson's disease motor subtypes and mood. Mov Disord, 27, 379-386.
39. Dore DD, Trivedi AN, Mor V, Friedman JH, & Lapane KL (2009) Atypical antipsychotic use and risk of fracture in persons with Parkinsonism. Mov Disord, 24, 1941-1948.
40. Guehl D, Cuny E, Benazzouz A, Rougier A, Tison F, Machado S, Grabot D, Gross C, Bioulac B, & Burbaud P (2006) Sideeffects of subthalamic stimulation in Parkinson's disease: Clinical evolution and predictive factors. Eur J Neurol, 13, 963-971.
41. Roche JJ,Wenn RT, Sahota O, & Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: Prospective observational cohort study. BMJ, 331, 1374.
42. Campbell AJ, Borrie MJ, & Spears GF (1989) Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol, 44, M112-M117.